BIO.NYSEBio-rad Laboratories, INC

Form 4: Bio-Rad Laboratories COO Reports Stock Transaction

Sentiment:

Insider Transaction (Form 4)

📋All filings for Bio-rad Laboratories, INC
🔒Login to Follow

Jonathan P. Divincenzo, President & COO of Bio-Rad Laboratories, Inc., reported multiple transactions in common stock on October 24, 2026.

Summary

  • Option exercise/conversion: acquired 1,869 Bio-Rad A Common Stock on October 24, 2026; holds 3,832 after (Direct).
  • Tax/exercise-price withholding: disposed of 951 Bio-Rad A Common Stock at $369.95 ($351,822) on October 24, 2026; holds 2,881 after (Direct).
  • Option exercise/conversion: disposed of 1,869 Restricted Stock Units on October 24, 2026; holds 3,740 after (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Jonathan P. Divincenzo — Officer (President & COO)

DateTransactionSecuritySharesPriceValueHeld After
2026-10-24Option exercise/conversionBio-Rad A Common Stock1,869——3,832
2026-10-24Tax/exercise-price withholdingBio-Rad A Common Stock951$370$351.8K2,881
2026-10-24Option exercise/conversionRestricted Stock Units1,869——3,740

Key Dates

DateDescription
2026-10-24Option exercise/conversion (1,869 shares)
2026-10-24Tax/exercise-price withholding (951 shares)
2026-10-24Option exercise/conversion (1,869 shares)

Keywords

insider transaction, Form 4, BIO BIO.B, BIO-RAD LABORATORIES, INC., neutral, Jonathan P. Divincenzo

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.